Literature DB >> 12789647

Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype.

Anna-Marie E Brassington1, Sandy S Sung, Reha M Toydemir, Trung Le, Amy D Roeder, Ann E Rutherford, Frank G Whitby, Lynn B Jorde, Michael J Bamshad.   

Abstract

Mutations in TBX5, a T-box-containing transcription factor, cause cardiac and limb malformations in individuals with Holt-Oram syndrome (HOS). Mutations that result in haploinsufficiency of TBX5 are purported to cause cardiac and limb defects of similar severity, whereas missense mutations, depending on their location in the T box, are thought to cause either more severe heart or more severe limb abnormalities. These inferences are, however, based on the analysis of a relatively small number of independent cases of HOS. To better understand the relationship between mutations in TBX5 and the variable expressivity of HOS, we screened the coding and noncoding regions of TBX5 and SALL4 for mutations in 55 probands with HOS. Seventeen mutations, including six missense mutations in TBX5 and two mutations in SALL4, were found in 19 kindreds with HOS. Fewer than 50% of individuals with nonsense or frameshift mutations in TBX5 had heart and limb defects of similar severity, and only 2 of 20 individuals had heart or limb malformations of the severity predicted by the location of their mutations in the T box. These results suggest that neither the type of mutation in TBX5 nor the location of a mutation in the T box is predictive of the expressivity of malformations in individuals with HOS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12789647      PMCID: PMC1180592          DOI: 10.1086/376436

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  The mutation spectrum in Holt-Oram syndrome.

Authors:  S J Cross; Y H Ching; Q Y Li; L Armstrong-Buisseret; S Spranger; S Lyonnet; D Bonnet; M Penttinen; P Jonveaux; B Leheup; G Mortier; C Van Ravenswaaij; C A Gardiner
Journal:  J Med Genet       Date:  2000-10       Impact factor: 6.318

Review 2.  Epidemiology of cardiovascular malformations: prevalence and risk factors.

Authors:  C A Loffredo
Journal:  Am J Med Genet       Date:  2000

3.  Holt-Oram syndrome: is there a "face"?

Authors:  Judith E Allanson; Ruth A Newbury-Ecob
Journal:  Am J Med Genet A       Date:  2003-05-01       Impact factor: 2.802

4.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

5.  TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome.

Authors:  S Merscher; B Funke; J A Epstein; J Heyer; A Puech; M M Lu; R J Xavier; M B Demay; R G Russell; S Factor; K Tokooya; B S Jore; M Lopez; R K Pandita; M Lia; D Carrion; H Xu; H Schorle; J B Kobler; P Scambler; A Wynshaw-Boris; A I Skoultchi; B E Morrow; R Kucherlapati
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

6.  Structure of the DNA-bound T-box domain of human TBX3, a transcription factor responsible for ulnar-mammary syndrome.

Authors:  Miquel Coll; Jonathan G Seidman; Christoph W Müller
Journal:  Structure       Date:  2002-03       Impact factor: 5.006

Review 7.  Current advances in Holt-Oram syndrome.

Authors:  Taosheng Huang
Journal:  Curr Opin Pediatr       Date:  2002-12       Impact factor: 2.856

8.  Three novel TBX5 mutations in Chinese patients with Holt-Oram syndrome.

Authors:  J Yang; D Hu; J Xia; Y Yang; B Ying; J Hu; X Zhou
Journal:  Am J Med Genet       Date:  2000-06-05

9.  Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study.

Authors:  J Burn; P Brennan; J Little; S Holloway; R Coffey; J Somerville; N R Dennis; L Allan; R Arnold; J E Deanfield; M Godman; A Houston; B Keeton; C Oakley; O Scott; E Silove; J Wilkinson; M Pembrey; A S Hunter
Journal:  Lancet       Date:  1998-01-31       Impact factor: 79.321

10.  Holt-Oram syndrome: a clinical genetic study.

Authors:  R A Newbury-Ecob; R Leanage; J A Raeburn; I D Young
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

View more
  34 in total

1.  Role of genomics in cardiovascular medicine.

Authors:  Giuseppe Novelli; Irene M Predazzi; Ruggiero Mango; Francesco Romeo; Jawahar L Mehta
Journal:  World J Cardiol       Date:  2010-12-26

2.  Identification of new mutations in the TBX5 gene in patients with Holt-Oram syndrome.

Authors:  W Heinritz; A Moschik; A Kujat; S Spranger; H Heilbronner; S Demuth; A Bier; M Tihanyi; S Mundlos; C Gruenauer-Kloevekorn; U G Froster
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

3.  A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome.

Authors:  Masao Murakami; Masayo Nakagawa; Eric N Olson; Osamu Nakagawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-06       Impact factor: 11.205

4.  An endocardial pathway involving Tbx5, Gata4, and Nos3 required for atrial septum formation.

Authors:  Mathieu Nadeau; Romain O Georges; Brigitte Laforest; Abir Yamak; Chantal Lefebvre; Janie Beauregard; Pierre Paradis; Benoit G Bruneau; Gregor Andelfinger; Mona Nemer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

5.  Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants.

Authors:  Clémence Vanlerberghe; Anne-Sophie Jourdain; Jamal Ghoumid; Frédéric Frenois; Aurélie Mezel; Guy Vaksmann; Bruno Lenne; Bruno Delobel; Nicole Porchet; Valérie Cormier-Daire; Thomas Smol; Fabienne Escande; Sylvie Manouvrier-Hanu; Florence Petit
Journal:  Eur J Hum Genet       Date:  2018-12-14       Impact factor: 4.246

6.  Functional analysis of two novel TBX5 variants present in individuals with Holt-Oram syndrome with different clinical manifestations.

Authors:  Débora Varela; Tatiana Varela; Natércia Conceição; Ângela Ferreira; Nuno Marques; Ana Paula Silva; Pedro Azevedo; Salomé Pereira; Ana Camacho; Ilídio de Jesus; M Leonor Cancela
Journal:  Mol Genet Genomics       Date:  2021-04-17       Impact factor: 3.291

7.  Differential regulation of Tbx5 protein expression and sub-cellular localization during heart development.

Authors:  Benjamin Bimber; Robert W Dettman; Hans-Georg Simon
Journal:  Dev Biol       Date:  2006-09-16       Impact factor: 3.582

8.  Hox5 interacts with Plzf to restrict Shh expression in the developing forelimb.

Authors:  Ben Xu; Steven M Hrycaj; Daniel C McIntyre; Nicholas C Baker; Jun K Takeuchi; Lucie Jeannotte; Zachary B Gaber; Bennett G Novitch; Deneen M Wellik
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

9.  A novel missense mutation in the TBX5 gene in a Saudi infant with Holt-Oram syndrome.

Authors:  Mohammad M Al-Qattan; Hussam Abou Al-Shaar
Journal:  Saudi Med J       Date:  2015-08       Impact factor: 1.484

Review 10.  Molecular genetics of congenital atrial septal defects.

Authors:  Maximilian G Posch; Andreas Perrot; Felix Berger; Cemil Ozcelik
Journal:  Clin Res Cardiol       Date:  2009-12-11       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.